Results and clinical responsibility.

1. Purpose

This policy governs commissioning, receipt, review, release, factual explanation, escalation and documentation of diagnostic and screening results. It distinguishes collection only work from Orchis IV laboratory packages and defines clinical boundaries and follow up responsibilities.

2. Pathway A, third party collection only

This pathway covers GP, consultant, clinic or external provider requests and client owned kits. Orchis IV normally verifies identity, obtains consent, collects, labels, processes and dispatches the sample. The external commissioning organisation normally selects the tests, receives its report, interprets the results and manages follow up. Orchis IV may not receive or review the report.

3. Pathway B, Orchis IV package

Orchis IV commissions the selected tests, collects and dispatches the sample, receives or accesses the authorised laboratory report, arranges a clinical review and releases the result securely. Every individual Orchis IV blood test package includes a nurse led online result discussion, including when no concern is identified. The discussion explains factual findings within scope and records any proportionate signposting or safety netting.

4. Responsibility matrix

5. Laboratory reports

The laboratory authors and retains the source analytical report. Orchis IV retains copies and clinical review notes for its services. You have rights of access to your personal information. Reports are not edited to obscure laboratory flags, comments, reference ranges or amendments.

For an Orchis IV package, use of a contracted laboratory does not remove responsibility that the law places on Orchis IV for the service it sold. For a client owned kit or external request, the commissioning provider may have separate responsibility for test selection, report interpretation and follow up.

6. Reference ranges and limitations

• Reference ranges vary by laboratory, method and individual factors and are aids to interpretation rather than absolute boundaries
• A normal result does not guarantee absence of disease or explain every symptom
• An abnormal result does not automatically establish a diagnosis
• Biological variation, timing, fasting, hydration, medicines, supplements, menstrual cycle, pregnancy, acute illness, sample quality and analytical method may affect results
• The range on the authorised report takes precedence over an internet or previous laboratory range

7. Nurse led explanation

For Orchis IV packages, the nurse may explain the tests, values, laboratory ranges, flags, limitations, general health information, recommended follow up and safety netting. This does not replace a full medical assessment, physical examination, diagnosis, specialist opinion, prescribing or ongoing disease management.

8. Medicines and treatment

Orchis IV does not prescribe and does not independently advise you to start, stop or change the dose of prescription medicine. Medication related findings are signposted to your GP, prescriber, consultant, pharmacist, NHS 111 or emergency care according to urgency.

9. Secure result release

For an Orchis IV package, the private Results Hub may provide the original laboratory report, an Orchis IV summary, relevant measurements and the recorded signposting pathway. A report uploaded for practitioner review is not visible to the client until an authorised practitioner releases it. Access requires the unique private link and a separate one time code sent to the client’s registered email address. The code expires after ten minutes, the secure session times out, documents are encrypted at rest and access is logged. Cliniko remains the clinical record for the included result discussion. Representatives require appropriate authority and identity verification.

10. Contact and GP information

You must provide accurate telephone, email, address and GP details and promptly report changes. We may restrict a package where the absence of a safe onward care route creates an unacceptable risk.

11. Result categories

12. Critical result procedure

• Verify the client, sample, result, authorised report and laboratory comments
• Record when the result was received and who reviewed it
• Follow the current contracted laboratory notification pathway and contact the client without avoidable delay
• Use neutral voicemail or text wording where detailed disclosure would be insecure
• Give clear verbal advice and written safety netting
• Use NHS 111 or 999 for urgent medical advice as appropriate, and make any further disclosure only where lawful, necessary and proportionate
• Continue risk based action where the client cannot be reached
• Document each attempt, disclosure, handover, advice and outcome

13. Failed contact and necessary disclosure

Where you cannot be reached, the clinician will assess severity, symptoms, result reliability, time elapsed, available GP or emergency details and the risk of serious harm. Necessary information may be shared without consent where lawful and proportionate to prevent serious harm, meet safeguarding duties, respond to an emergency or comply with law. The decision and disclosure will be documented.

14. Written safety netting

Urgent and critical verbal information will normally be confirmed in writing, stating the concern, action required, warning symptoms, the advised service and that Orchis IV is not an emergency service. Use NHS 111 or 999 for urgent medical advice as appropriate.

15. Corporate screening

Individual results are disclosed to the participant, not the employer. The employer may receive only genuinely anonymous aggregate reporting unless the participant specifically authorises a lawful individual disclosure or a serious safety or legal basis requires limited information sharing.

16. Corrected reports

The original report is retained in the audit trail. A corrected report is clearly identified, reviewed for clinical significance and communicated promptly where material. Earlier information is corrected, relevant healthcare professionals are notified where appropriate, and incident or duty of candour review is considered.

17. Repeat and confirmatory testing

Repeat or confirmatory testing may be required for unexpected, borderline, compromised, screening or clinically inconsistent results. A repeat may confirm, modify or contradict the first result. Urgent action will not be unreasonably delayed while awaiting confirmation where current information indicates significant risk.

18. Incidental findings

Unexpected findings are assessed for urgency, explained without unsupported diagnosis, safety netted and signposted for appropriate GP or specialist assessment. We cannot guarantee detection of every incidental condition.

19. Test specific limitations

• HbA1c and glucose may be affected by red cell conditions, transfusion, pregnancy and acute illness
• Lipids vary with fasting, alcohol, illness, medicines and wider cardiovascular risk
• Kidney estimates are affected by muscle mass, hydration and acute change
• Liver tests are nonspecific and may be influenced by medicines, alcohol, exercise and nonliver causes
• Thyroid and reproductive hormones require clinical context, medicine review and sometimes timed or repeat sampling
• PSA is not a standalone cancer diagnosis
• An ECG records only the period captured and does not exclude intermittent or other heart conditions
• ABPM depends on cuff fit, activity, diary quality and adequate readings
• Urinalysis and body composition readings are screening tools and may require confirmation

20. Sample failure and consumer rights

If an act or omission by Orchis IV compromises a sample or report pathway, we will offer an appropriate repeat, price reduction or refund. A new charge may apply where the cause is a client owned kit, biological factor, preparation issue or event genuinely outside our reasonable control, but it will be explained before repeat work.

Nothing in this policy limits your statutory rights. You retain remedies where Orchis IV or a provider for whose performance we are legally responsible fails to provide the contracted service with reasonable care and skill.

21. Turnaround estimates and delays

Turnaround estimates begin after laboratory receipt and acceptance. Weekends, specialist referral, quality control, repeat analysis, sample problems and courier delays may extend them. We track outstanding reports, update you about a material delay and escalate an unexplained delay to the laboratory.

22. Onward follow up

For results we commissioned, Orchis IV is responsible for safe review, communication within scope, factual explanation, safety netting and urgent or critical escalation. You are responsible for responding to contact attempts, attending recommended GP or specialist review, arranging recommended repeat tests, following urgent advice and seeking help for persistent or worsening symptoms.

23. Private testing and NHS care

Private testing does not replace GP registration, NHS screening, chronic disease monitoring, specialist appointments, medicine monitoring, urgent assessment or emergency services. A screening package examines only the listed markers and cannot guarantee diagnosis, absence of disease, treatment eligibility or a particular outcome.

24. Documentation and audit

Clinical records include identifiers, tests, collection and dispatch details, report receipt, reviewer, classification, information provided, contact attempts, GP or NHS escalation, written safety netting, disclosures, amendments, repeats and closure or handover. We maintain a secure results register and audit review timeliness, failed contact, critical escalation, laboratory delays, secure release and corrective action.